Check-Cap Shares Move as MBody AI Merger Heads Toward Nasdaq Wrap
Check-Cap Ltd. shares are in focus before the U.S. open Wednesday, after the company said its merger partner MBody AI plans to show its enterprise robotics platform to institutional investors in Miami this week. Check-Cap isn’t just a medical-diagnostics name anymore. The small Nasdaq-listed stock is trying to remake itself as a bet on embodied artificial intelligence, or software for robots and machines to act out in the real world, via its planned merger with MBody AI.